International Journal of Scientific and Research Publications

IJSRP, Volume 10, Issue 6, June 2020 Edition [ISSN 2250-3153]


Development of Genlisa™ SARS-CoV-2 ELISA (KBVH015-2 and KBVH015-8) for Estimation of Novel Coronavirus (nCoV/CoV-2) IgG Antibodies in serum and plasma
      Krisha Jain, Atul Gadhave, Anitha Florance, and Dr Kalpesh Jain
Abstract: Researchers working on nCOV-2019 identified a unique protein, the Spike protein, on the surface of the coronavirus, which helped in understanding the method of transmission of the virus. Novel coronavirus uses this spike protein to infect a human cell by binding to the membrane. Detection of antibodies to SARS-COV-2 can help in diagnosis of disease, and also has implications in developing and monitoring patient therapeutics as well as in vaccine and therapy research. As many cases worldwide are asymptomatic (and particularly in India), detection of antibodies in serum and plasma can also identify infection in a patient

Reference this Research Paper (copy & paste below code):

Krisha Jain, Atul Gadhave, Anitha Florance, and Dr Kalpesh Jain (2020); Development of Genlisa™ SARS-CoV-2 ELISA (KBVH015-2 and KBVH015-8) for Estimation of Novel Coronavirus (nCoV/CoV-2) IgG Antibodies in serum and plasma; International Journal of Scientific and Research Publications (IJSRP) 10(06) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.10.06.2020.p10238
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.